DOCSLIB.ORG

Trustee Rachel Chernos Lin Ward 11 • Don Valley West Toronto District School Board 416-395-8787 • [email protected]

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Trustee Rachel Chernos Lin Ward 11 • Don Valley West Toronto District School Board 416-395-8787 • Rachel.Chernoslin@Tdsb.On.Ca Trustee Rachel Chernos Lin Ward 11 • Don Valley West Toronto District School Board 416-395-8787 • [email protected] Dear friends, It's hard to believe we are already in the middle of May, with only a month and a half of school to go. I hope everyone had a lovely Mother's Day weekend (that seems like weeks ago to me somehow...), and I would like to wish all those celebrating the end of Ramadan tomorrow a joyful Eid al-Fitr. Eid Mubarak! With everything going on the world, may this special day bring peace, love, happiness, and health. Although the case counts in the GTA remain stubbornly high, vaccine rollout is ramping up. This past week saw the announcement that the Pfizer vaccine is now approved for those 12 years of age and older, and all current in-person education workers are now eligible to book vaccines. Alberta has begun registering those 12 and up for appointments, so we hope Ontario will soon follow suit. These developments bring hope and suggest our current school situation may improve significantly by summer if everyone follows the rules and gets vaccinated when their turn comes. I will conitnue to advocate for making a safe return to school linked to our Province's vaccination strategy. For a more stable school year next year, it is imperative our Province prioritize making two doses available to all education workers and age-eligiblle chiildren in time to develop proper immunity before start of school. In Ward 11, our vaccination partners at Sunnybrook Hospital and Michael Garron Hospital have been instrumental in Toronto's vaccine rollout, and their outreach and school support throughout the pandemic has been such a help to our local schools and communities. A special shout-out however must go to Sunday's pop-up clinic in Thorncliffe Park, where a City of Toronto daily record of 4,048 vaccines were administered in just one day! This location ran from 12pm to 12am, enabling Thorncliffe and Flemingdon residents observing Ramadan to come after breaking their fasts. The partnership between the team at Michael Garron Hospital and local community residents and organizations working together on vaccine rollout have been nothing short of amazing in their efforts to meet the needs of the communities they serve. Kudos to all involved, including those who came out all day, and well into the night, to get vaccines! In Board news, last week saw great starts to Asian Heritage Month & Jewish Heritage Month. The launch of Asian Heritage month was on Tuesday, May 4 and included an excellent presentation about a new package of resources focussing on anti-Asian racism produced jointly by TDSB and the Elementary Teachers Federation of Ontario (ETFO). The following day, trustees and the Equity Policy Community Advisory Committee brought forward a motion asking staff to report back in the fall on an implementation plan regarding how these resources are being used in our schools. This motion passed unanimouly at committee and will go to Board for final approval on May 26, 2021. While anti-Asian racism has been a persistent problem in Canada for many years, we know from our own TDSB Human Rights Report that incidents of this kind have been on the rise in our schools and have become increaasinly common since the start of the pandemic country-wide. At the TDSB we are committed to interrupting, naming and dealing with all incidents of racism and oppression, and we look forward to learning more in the fall about how educators are incorporating these resources into their work. As mentioned in my last newsletter, the Jewish and Asian heritage committees are working on a joint venture called "Chicken Soup, Chicken Soup". As part of this initiative, the TDSB is seeking chicken soup and dumpling recipes from staff, students and their families from all cultures to incorporate into a cookbook to be sold next year with profits going towards the Foundation for Student Success, the TDSB's charitable partner that helps to fund breakfast programs in TDSB schools. To learn more about this initiative, and to submit your family recipe, please click here. Planning for the 2021/2022 School Year On Friday, May 7, trustees (and the public) had their first glimpse of next year's planning and ministry guidance for the 2021/2022 school year at a special Planning & Priorities Committee meeting (see the full slide presentation, and even more is below). Selecting Remote or In-Person learning for September It was confirmed that the Ministry of Education is requiring that all school boards once again provide both in-person and remote learning options for the new school year. Understanding that this is a very difficult decision to make with incomplete information about the Covid-19 pandemic (i.e. what covid case counts will be like by end of summer, where we will be with vaccine rollout, etc), schools boards must neverthless begin planning and hiring so that we are ready to go in September. As a result, staff has indicated that we will be asking everybody to select whether their children will be attending school in-person or fully remote by June 1, 2020 (additional information will be provided around May 17, registration starts May 25). Those not registering a choice will see their children placed In-Person. Please note (i): The remote learning model will look different from most of this year. At this point in time, staff is indicating that we will not have a central Virtual School. Instead, remote learning will be provided through the local 'brick-and-mortar' schools or in 'hubs' (students from a smaller group of schools). Recognizing the importance of connection to local schools, and lacking funding from the government to administer a centralized virtual school this coming year, this is seen to be the best approach to support our staff, students and families. Please note (ii): At this point, we still await detailed guidance from the Ministry as to the school day model for in-person secondary school in Toronto. As you may know, this year the Ministry required all GTA boards (and several others, where Covid-19 was more pronounced) to follow an "adapted" timetable for in-person learning; students were cohorted into groups of roughly 15 or less, spending part time in-person and part-time in remote learning. The Ministry has indicated that for the 2021-2021 school year, high-school students must not have more than two cohorts. Today, staff announced in a message to all families that next year the high school schedule will again be divided up in Quadmesters, with two courses at a time (September - Mid November; Mid-November - January; February - mid-April; Mid-April - June). However, we do not know what the daily schedule will look like, as we have not been given parameters regarding size of cohorts. We have been told to expect this guidance to come in August, once there is a clearer picture of case counts and vaccine rollout. As a result, staff are planning for several contingencies and reviewing options to make all of these work best for students based on the learning from this year's schedule. Please note (iii): a date to switch between models is currently part of the plans, but not until February. Switching students between models is complicated and destabilizing to the entire system because it can lead to major disruptions of classes. As a result, staff are suggesting only one switch date. With other Trustees, I have stressed that as much as possible detailed information needs to be provided to students and families so that they can make informed choices. Provincial Funding This past week, Boards also recieved information about the 2021-2022 Grants for Student Needs (GSN), the funding that makes up much of the Board's Budget. The Ministry also provided details regarding the continuation of the temporary COVID-19 funding along with learning recovery and renewal support for next year. We are encouraged to see the Ministry’s continued commitment to COVID-related funding for this September so that our students and staff can return to school safely with the supports they need for a successful school year. Ward 11 Updates: Hodgson addition; Yonge-Eglinton PART (affecting John Fisher) In Ward 11, last week was also busy. We had two important online community meetings, one regarding the addition to be built at Hogson Middle School (with construction to start as early as September 2022), and the other regarding the Yonge-Eglinton Program Area Review (PART). I was very pleased to see excellent turnout at both meetings, with the community providing constructive feedback for staff on both topics. To learn more about the Hodgson project and the PART, you can browse information provided in the Accommodation Review page on the TDSB website (under "Current Other Studies" - Hodgson Middle School New Addition and under "Current Program Area Reviews - Eglinton JPS, John Fisher JPS, and Bannockburn). There are follow-up meetings/surveys that may be of interest to families regaring both of these projects. These include: A follow-up meeting about the Hodgson Middle School addition scheduled for Monday, May 17, 6:30-8:00pm (pre-registration already available). The Yonge-Eglinton Phase 2 Program Area Review has a seperate website with more information including a Frequently Asked Questions section that is being regularly updated. A second Feedback survey was launched on May 5. It seeks input on the current recommendations as modified by the Program Area Review Team. Results of the first feedback survey were reviewed and shared with the Program Area Review Team and the original recommendations have been modified to reflect some of the feedback that was received.
Load more

Recommended publications
  • The Epidemiology of COVID-19 in Canada in 2020: the Pre-Vaccine Era February 2021
    The Epidemiology of COVID-19 in Canada in 2020: The Pre-Vaccine Era February 2021 An RSC Policy Briefing The Epidemiology of COVID-19 in Canada in 2020: The Pre-Vaccine Era An RSC Policy Briefing Authors Wendy Sligl (Chair) University of Alberta David Waldner University of Alberta Jennie Johnstone University of Toronto Robyn Harrison University of Alberta Duncan Webster Dalhousie University Lynora Saxinger University of Alberta Peer Review Monitor Tom Marrie, FRSC Dalhousie University Peer Reviewers Nick Daneman University of Toronto Rob Fowler University of Toronto Srinivas Murthy The University of British Columbia David Patrick The University of British Columbia Dan Reid Dalhousie University Robert Strang Chief Medical Officer of Health, Nova Scotia Suggested citation for Policy Briefing Report: Waldner D, Harrison R, Johnstone J, Saxinger L, Webster D, Sligl W. The Epidemiology of COVID-19 in Canada in 2020: The Pre-Vaccine Era. Royal Society of Canada. 2021 Cover Art Christine De Vuono, For Your Own Good, (2020) Over the course of the pandemic, those in long term care facilities have been hit hardest with the impact of COVID-19 outbreaks. The response has been to lock down care homes and ban visitors, volunteers and even care packages, as attempts to stop the virus from entering the facility. This had the unintended, but very real consequence of isolating our most vulnerable from those who care for and love them. “For Your Own Good”, made of 100 carved figures from identical bars of soap, then placed in mason jars, which in turn are placed on shelves, allow us to look in on the miniature elderly figures, who look out at us.
    [Show full text]
  • Celebrating 100 Years
    AMERICANa CERAMICting SOCIETY ars Celebr 100 ye bulletinemerging ceramics & glass technology JUNE/JULY 2021 Student perspectives on facing uncertainty New issue inside: JUNE/JULY 2021 • VOLUME 2 • ISSUE 2 www.ceramics.org/ceramicandglassmanufacturing PREPARING FOR CONTINGENCIES HELPED COMPANIES GROW DURING THE PANDEMIC THE ROCKY ROAD BACK TO ‘LIVE’: IMPACT OF THE PANDEMIC FROM A TRADE SHOW PERSPECTIVE Materials Genome Initiative at 10 years | 2021-2022 ACerS Board members and directors When it Comes to Heat, We Sweat the Details! Your firing needs are unique. Our laboratory can run tests to So why use an “off the shelf” help identify your process kiln in your process? boundaries. Through our toll firing facility, we can At Harrop, we get it. help to further define That’s why, for over a the equipment/ century, we’ve been processing putting in the hard work combination that to design and service works best for your custom kilns. Is it harder material. And if you to do things this way? are not ready for a Yes. Is the extra effort new kiln, we can toll worth it? You bet! fire your material to help meet your At Harrop, we don’t production needs. stop there. If you aren’t sure what you Does your current need, we can help. kiln company sweat the details? www.harropusa.com 1.614.231.3621 Harrop Ad Sweat the Details ACerS Full Size w 100 logo.indd 1 5/21/20 9:33 AM contents June/July 2021 • Vol. 100 No.5 feature articles department News & Trends . 3 Materials Genome Initiative 10 years later: Spotlight .
    [Show full text]
  • Effectiveness of Bnt162b2 and Mrna-1273 Covid-19 Vaccines BMJ: First Published As 10.1136/Bmj.N1943 on 20 August 2021
    RESEARCH Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines BMJ: first published as 10.1136/bmj.n1943 on 20 August 2021. Downloaded from against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study Hannah Chung,1 Siyi He,1 Sharifa Nasreen,1 Maria E Sundaram,1,2 Sarah A Buchan,1,2,3,4 Sarah E Wilson,1,2,3,4 Branson Chen,1 Andrew Calzavara,1 Deshayne B Fell,1,5,6 Peter C Austin,1,7 Kumanan Wilson,5,8,9 Kevin L Schwartz,1,2,3 Kevin A Brown, 1,2,3 Jonathan B Gubbay,3,10 Nicole E Basta,11 Salaheddin M Mahmud,12 Christiaan H Righolt,12 Lawrence W Svenson,13,14,15,16 Shannon E MacDonald,15,17 Naveed Z Janjua,18,19 Mina Tadrous,1,20,21 Jeffrey C Kwong,1,2,3,4,22,23 on behalf of the Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators For numbered affiliations see ABSTRACT received at least one dose of vaccine. Among end of the article OBJECTIVE participants who tested positive, 2479 (4.7%) were Correspondence to: J Kwong To estimate the effectiveness of mRNA covid-19 admitted to hospital or died. Vaccine effectiveness [email protected] vaccines against symptomatic infection and severe against symptomatic infection observed ≥14 days (or @DrJeffKwong on Twitter ORCID 0000-0002-7820-2046) outcomes (hospital admission or death). after one dose was 60% (95% confidence interval Additional material is published DESIGN 57% to 64%), increasing from 48% (41% to 54%) at online only.
    [Show full text]
  • April 28, 2021 Update Dear Neighbours, I Would Like to Continue
    April 28, 2021 Update Dear Neighbours, I would like to continue to thank everyone for their efforts during these difficult times. It has been difficult for everyone. We must continue to fight the spread of COVID-19 and keep ourselves and our community safe by following the public health measures in place. Remember, our mental health is paramount, we need to continue to take care of ourselves and seek support if needed. You’re Invited: Please send me your questions for Dr. Shovita Padhi on the planning of vaccination sites across the City of Toronto. To submit questions about vaccine planning and distribution, please click here. To join the meeting at the time of the event, please click here. Watch Scarborough-Guildwood’s past Live Town Hall meetings on my YouTube channel - like and subscribe for more videos! Ensure you Subscribe to the channel! The City of Toronto remains subject to a provincial wide Stay-at-Home order. The provincial wide shutdown requires all residents to remain home except for essential purposes. I encourage everyone to review the Province's COVID-19 public health measures and advice, the City’s Guide for Toronto Residents and Changes to City Services for the most up-to-date information on public health guidelines and regulations. Where to get accurate COVID-19 vaccine information There is a lot of incorrect information about the COVID-19 vaccines on social media and group chats, such as WhatsApp. Accurate and trusted information can be found on the City’s COVID- 19: Vaccines webpage. If you have questions about the vaccines, you should speak with your doctor or health care provider.
    [Show full text]
  • May 20, 2021 Update Dear Neighbours, I Would Like To
    May 20, 2021 Update Dear Neighbours, I would like to continue to thank everyone for their efforts during these difficult times. It has been difficult for everyone. We must continue to fight the spread of COVID-19 and keep ourselves and our community safe by following the public health measures in place. Remember, our mental health is paramount, we need to continue to take care of ourselves and seek support if needed. *NEW* Today, the Ontario government released its three-step Roadmap to Safely Reopen the Province. Roadmap to Reopen outlines three steps to easing public health measures, guided by the following principles: • Step One An initial focus on resuming outdoor activities with smaller crowds where the risk of transmission is lower, and permitting retail with restrictions. This includes allowing outdoor gatherings of up to 10 people, outdoor dining with up to four people per table and non-essential retail at 15 per cent capacity. • Step Two Further expanding outdoor activities and resuming limited indoor services with small numbers of people where face coverings are worn. This includes outdoor gatherings of up to 25 people, outdoor sports and leagues, overnight camps, personal care services where face coverings can be worn and with capacity limits, as well as indoor religious services, rites or ceremony gatherings at 15 per cent capacity. • Step Three Expanding access to indoor settings, with restrictions, including where there are larger numbers of people and where face coverings can’t always be worn. This includes indoor sports and recreational fitness; indoor dining, museums, art galleries and libraries, and casinos and bingo halls, with capacity limits.
    [Show full text]
  • Hannah Jackson Amy Skinner Jeevana Rajkumar
    #PASSIONTOPURPOSE VIRTU A L YOUTH LE A DERSHIP SUMMIT ADAPT, EVOLVE AND LEAD IN A POST-PANDEMIC WORLD WELCOME 2 ABOUT 3 EVENT SCHEDULE 4 DAY 1 5 CONTENTS DAY 2 17 OF DAY 3 31 DAY 4 48 BLE A DAY 5 66 T I want to welcome you to the Passion to Purpose event 2021, hosted by The Duke of Edinburgh’s International Award - Canada, as part of the Canada Service Corps initiative. We hope that this forum does exactly as its title suggests: help to inspire and motivate you to turn whatever you are passionate about into something purposeful, something that helps your community, however you wish to define that term.If you are attending this conference you have expressed a desire to take on a role as a Leader in your community. This forum is designed to encourage you to identify the skills, attributes and drivers that might make you more successful in this leadership role. Successful in the sense of drawing others into your project, engaging fully with partners and others members of our wonderful civil society amd WELCOME ensuring that what you set out to achieve has real community impact. I hope you enjoy your initial experience and are able to take away from this week something that helps you build a future of which you are proud to be a part and for which you can feel responsible. Stephen De-Wint National Executive Director The Duke of Edinburgh’s International Award - Canada 2 PASSION TO PURPOSE Passion to Purpose (P2P) is a comprehensive, youth forum that is designed to foster community service through civic leadership in young Canadians.
    [Show full text]
  • Debates of the House of Commons
    43rd PARLIAMENT, 2nd SESSION House of Commons Debates Official Report (Hansard) Volume 150 No. 083 Monday, April 19, 2021 Speaker: The Honourable Anthony Rota CONTENTS (Table of Contents appears at back of this issue.) 5773 HOUSE OF COMMONS Monday, April 19, 2021 The House met at 11 a.m. members to be mindful of their words, which may be heard by oth‐ er members and by many Canadians as being offensive. ● (1105) Prayer The Speaker: I want to thank the hon. member for his point of order. I take it under advisement. I will return to the House with a ● (1100) ruling on that. [English] POINTS OF ORDER PRIVATE MEMBERS' BUSINESS COMMENTS BY THE MEMBER FOR CLOVERDALE—LANGLEY CITY [Translation] Mr. Robert Oliphant (Parliamentary Secretary to the Minis‐ ter of Foreign Affairs, Lib.): Mr. Speaker, I rise on a point of or‐ EMPLOYMENT INSURANCE ACT der. Mrs. Claude DeBellefeuille (Salaberry—Suroît, BQ) moved On Friday, April 16, at the last sitting of this House, we had de‐ that Bill C-265, An Act to amend the Employment Insurance Act bate on Bill C-6, an act to amend the Criminal Code, conversion (illness, injury or quarantine), be read the second time and referred therapy. During the question-and-answer period following my to a committee. speech opening the morning's debate, contrary to Standing Order She said: Mr. Speaker, this is it. We made it. It is finally time to 18, the member for Cloverdale—Langley City used language that debate a very compassionate, common-sense bill that seeks to ex‐ was offensive to me and, in my understanding, to many other mem‐ tend special employment insurance sickness benefits from bers of the House.
    [Show full text]
  • Horizon Scanning Status Report December 2020
    PCORI Health Care Horizon Scanning System Volume 2 Issue 4 Horizon Scanning Status Report December 2020 Prepared for: Patient-Centered Outcomes Research Institute 1828 L St., NW, Suite 900 Washington, DC 20036 Contract No. MSA-HORIZSCAN-ECRI-ENG-2018.7.12 Prepared by: ECRI Institute 5200 Butler Pike Plymouth Meeting, PA 19462 Investigators: Randy Hulshizer, MA, MS Damian Carlson, MS Christian Cuevas, PhD Andrea Druga, MSPAS, PA-C Marcus Lynch, PhD, MBA Misha Mehta, MS Prital Patel, MPH Brian Wilkinson, MA Donna Beales, MLIS Jennifer De Lurio, MS Eloise DeHaan, BS Eileen Erinoff, MSLIS Cassia Hulshizer, BBA Madison Kimball, MS Maria Middleton, MPH Melinda Rossi, BS Diane Robertson, BA Kelley Tipton, MPH Rosemary Walker, MLIS Andrew Furman, MD, MMM, FACEP Statement of Funding and Purpose This report incorporates data collected during implementation of the Patient-Centered Outcomes Research Institute (PCORI) Health Care Horizon Scanning System, operated by ECRI under contract to PCORI, Washington, DC (Contract No. MSA-HORIZSCAN-ECRI-ENG-2018.7.12). The findings and conclusions in this document are those of the authors, who are responsible for its content. No statement in this report should be construed as an official position of PCORI. An intervention that potentially meets inclusion criteria might not appear in this report simply because the Horizon Scanning System has not yet detected it or it does not yet meet the inclusion criteria outlined in the PCORI Health Care Horizon Scanning System: Horizon Scanning Protocol and Operations Manual. Inclusion or absence of interventions in the horizon scanning reports will change over time as new information is collected; therefore, inclusion or absence should not be construed as either an endorsement or a rejection of specific interventions.
    [Show full text]
  • The Innovation Awards 2020
    DECEMBER 2020 # 71 In My View Feature Best Practice NextGen The benefits of 3D printing How far have we come Top tips for E&L Reviewing setbacks and for biopharma against COVID-19? analysis successes in gene therapy 10 24 – 31 36 – 39 46 – 49 The Innovation Awards 2020 Celebrating 2020’s top pharma development and manufacturing technologies 14 – 21 www.themedicinemaker.com Do You Want to Learn More About monoclonal Antibody Production? Today’s bioprocess professionals need to stay on top of many things: Scale-up parameters and equipment capabilities, control strategies and automation, validation requirements and docu- mentation to name a few. New fields of applications like stem cell technology are evolving into powerful tools of the future. Become a bioprocessing. Join us at www.eppendorf.com/bioprocess Eppendorf® and the Eppendorf Brand Design are registered trademarks of Eppendorf AG, Germany. www.eppendorf.com /bioprocess All rights reserved, including graphics and images. Copyright © 2020 by Eppendorf AG. Is it Time to Reevaluate Our Priorities? The COVID-19 vaccines demonstrate what’s possible Editorial when disease is tackled as a genuine priority he whole research and development community is working hard to bring us that [COVID-19] breakthrough sooner rather than later,” wrote TStephanie Sutton in her November editorial (1). And here we are, just one month later, with not one but three breakthroughs. Pfizer (2) and Moderna (3) are both claiming around 95 percent efficacy in their vaccine studies, involving 44,000 and 30,000 volunteers respectively. And then we had AstraZeneca and the University of Oxford announcing that their vaccine, which should be cheaper and easier to distribute than the aforementioned mRNA approaches, is 70 percent effective (4).
    [Show full text]
  • COVID-19 and the State of Global Mobility in 2020
    COVID-19 and the State of Global Mobility in 2020 Meghan Benton Jeanne Batalova Samuel Davidoff-Gore Timo Schmidt The opinions expressed in the report are those of the authors and do not necessarily reflect the views of the International Organization for Migration (IOM). The designations employed and the presentation of material throughout the report do not imply expression of any opinion whatsoever on the part of IOM concerning legal status of any country, territory, city or area, or of its authorities, or concerning its frontiers or boundaries. IOM is committed to the principle that humane and orderly migration benefits migrants and society. As an intergovernmental organization, IOM acts with its partners in the international community to: assist in meeting the operational challenges of migration; advance understanding of migration issues; encourage social and economic development through migration; and uphold the human dignity and well-being of migrants. The Migration Policy Institute (MPI) is an independent, nonpartisan think tank that seeks to improve immigration and integration policies through authoritative research and analysis, opportunities for learning and dialogue, and the development of new ideas to address complex policy questions. MPI is an independent, nonpartisan policy research organization that adheres to the highest standard of rigor and integrity in its work. All analysis, recommendations and policy ideas advanced by MPI are solely determined by its researchers. This publication was made possible through support provided by the German Federal Foreign Office. The opinions expressed herein are those of the authors and do not necessarily reflect the views of the German Federal Foreign Office. Publisher: International Organization for Migration Publisher: Migration Policy Institute 17 Route des Morillons 1400 16th St NW P.O.
    [Show full text]
  • Downloaded Or Used a Contact Tracing/Exposure Notification App (77%) and Who Would Not Receive a COVID-19 Vaccine When Available (20%) Or Were Unsure (12%)
    COVID-19 Evidence Support Team EVIDENCE SEARCH REPORT Review Question: How effective are COVID-19 vaccines? Context: Benefits following dose/second dose; how well it prevents infections; evidence of limiting viral replication or spread; preventing hospitalization; preventing ventilation; preventing “long COVID” (long term symptoms), duration of immunity (natural and vaccinated). FDA cold chain changes. Effectiveness against P1 variant. Booster doses for variants. Does not include vaccine willingness/acceptance (to be run as a separate search) Review Code: INF031801v3 ESR Complete Date: April 30, 2021 Cite As: Miller, L., Howell-Spooner, B.. How effective are COVID-19 vaccines? 2021 Apr 30, Document no.: INF031801v3 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2021. 107 p. (CEST evidence search report). Librarian Notes & Comments Hello All, We’ve run this update for the databases from March 18th to April 30th, and searched for grey literature between those dates as well. Thanks, Brianna and Lukas Search Results: Guidelines, Summaries & Other Grey Literature Government Health Canada Extended dose intervals for COVID-19 vaccines to optimize early vaccine rollout and population protection in Canada in the context of limited vaccine supply. April 14, 2021. https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee- on-immunization-naci/extended-dose-intervals-covid-19-vaccines-early-rollout-population- protection.html Public Health Agency of Canada Disclaimer This information is provided as a service by the Saskatchewan Health Authority and University of Saskatchewan Libraries. Professional librarians conduct searches of the literature. Results are subject to the limitations of the databases and the specificity, broadness and appropriateness of the search parameters presented by the requester.
    [Show full text]
  • Non-Viral COVID-19 Vaccine Delivery Systems
    Advanced Drug Delivery Reviews 169 (2021) 137–151 Contents lists available at ScienceDirect Advanced Drug Delivery Reviews journal homepage: www.elsevier.com/locate/addr Non-viral COVID-19 vaccine delivery systems Kyung Soo Park a,b,1, Xiaoqi Sun b,c,1, Marisa E. Aikins b,c,1, James J. Moon a,b,c,⁎ a Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA b Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, USA c Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI 48109, USA article info abstract Article history: The novel corona virus termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread Received 10 October 2020 throughout the globe at a formidable speed, causing tens of millions of cases and more than one million deaths Received in revised form 20 November 2020 in less than a year of its report in December 2019. Since then, companies and research institutions have raced Accepted 13 December 2020 to develop SARS-CoV-2 vaccines, ranging from conventional viral and protein-based vaccines to those that are Available online 17 December 2020 more cutting edge, including DNA- and mRNA-based vaccines. Each vaccine exhibits a different potency and du- ration of efficacy, as determined by the antigen design, adjuvant molecules, vaccine delivery platforms, and im- munization method. In this review, we will introduce a few of the leading non-viral vaccines that are under clinical stage development and discuss delivery strategies to improve vaccine efficacy, duration of protection, safety, and mass vaccination. ©2020ElsevierB.V.Allrightsreserved.
    [Show full text]